Sanctuary Advisors LLC Has $426,000 Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Sanctuary Advisors LLC grew its stake in Utah Medical Products, Inc. (NASDAQ:UTMD) by 16.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,961 shares of the medical instruments supplier’s stock after purchasing an additional 963 shares during the period. Sanctuary Advisors LLC owned about 0.21% of Utah Medical Products worth $426,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Golden State Wealth Management LLC acquired a new stake in Utah Medical Products during the fourth quarter worth about $31,000. R Squared Ltd acquired a new stake in shares of Utah Medical Products during the 4th quarter worth approximately $49,000. BNP Paribas Financial Markets grew its holdings in shares of Utah Medical Products by 102.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after purchasing an additional 566 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Utah Medical Products during the fourth quarter valued at approximately $157,000. Finally, Virtu Financial LLC acquired a new position in shares of Utah Medical Products in the third quarter valued at $207,000. 69.60% of the stock is currently owned by institutional investors and hedge funds.

Utah Medical Products Stock Performance

Shares of Utah Medical Products stock opened at $59.61 on Monday. Utah Medical Products, Inc. has a twelve month low of $58.87 and a twelve month high of $77.33. The firm has a market cap of $202.20 million, a P/E ratio of 15.09 and a beta of 0.08. The firm’s 50-day simple moving average is $61.20 and its 200-day simple moving average is $64.17.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be issued a dividend of $0.305 per share. The ex-dividend date is Friday, March 14th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.05%. Utah Medical Products’s payout ratio is presently 30.89%.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.